Market Research Logo

Global Burkitt Lymphoma Therapeutics Market 2018-2022

Global Burkitt Lymphoma Therapeutics Market 2018-2022

About Burkitt Lymphoma

Burkitt Lymphoma is one of the rare types of B-cell non-Hodgkin’s lymphoma. It constitutes about 1-2% of all types of non-Hodgkins lymphoma types. It progresses at a very high rate and could be fatal if left untreated during the early stages.

Technavio’s analysts forecast the Global Burkitt Lymphoma Market to grow at a CAGR of 3.07% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the Burkitt lymphoma market. To calculate the market size, the report considers the revenue generated from Burkitt lymphoma market.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Burkitt lymphoma market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Biogen
  • F. Hoffmann-La Roche
  • Merck Sharp & Dohme
  • Novartis
  • Spectrum Pharmaceuticals
Market driver
  • Increasing cases of EBV and HIV-1 in patients with Burkitt lymphoma in Africa
  • For a full, detailed list, view our report
Market challenge
  • High cost of the treatment
  • For a full, detailed list, view our report
Market trend
  • Heavy investments in R&D for oncology drugs
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


  • Executive summary
  • Scope of the report
  • Research methodology
  • Disease overview
    • Burkitt lymphoma
  • Market landscape
    • Market ecosystem
      • Table Parent market
      • Table Global Burkitt lymphoma therapeutics market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2017
      • Table Market size 2017
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast 2017-2022
      • Table Global Burkitt lymphoma therapeutics market - Market size and forecast 2017-2022 ($ mn)
      • Table Global Burkitt lymphoma therapeutics market - Year-over-year growth 2018-2022 (%)
  • Five forces analysis
    • Table Five forces analysis 2017
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2017
  • Pipeline
    • Table Pipeline landscape by development phase
    • Table Key clinical trials
  • Market segmentation by drug class
    • Segmentation by drug class
      • Table Global Burkitt lymphoma therapeutics market by drug class - Market share 2017-2022 (%)
    • Comparison by drug class
      • Table Comparison by drug class
    • Biological - Market size and forecast 2017-2022
      • Table Global Burkitt lymphoma biological therapeutics market - Market size and forecast 2017-2022 ($ mn)
      • Table Global Burkitt lymphoma biological therapeutics market - Year-over-year growth 2018-2022 (%)
    • Small molecule - Market size and forecast 2017- 2022
      • Table Global Burkitt lymphoma small molecule therapeutics market- Market size and forecast 2017-2022 ($ mn)
      • Table Global Burkitt lymphoma small molecule therapeutics market - Year-over-year growth 2018-2022 (%)
    • Market opportunity by drug class
      • Table Market opportunity by drug class
  • Customer landscape
    • Table Customer landscape
  • Regional landscape
    • Geographical segmentation
      • Table Global Burkitt lymphoma therapeutics market by geography - Market share 2017-2022 (%)
    • Regional comparison
      • Table Regional comparison
    • Americas - Market size and forecast 2017-2022
      • Table Burkitt lymphoma therapeutics market in Americas - Market size and forecast 2017-2022 ($ mn)
      • Table Burkitt lymphoma therapeutics market in Americas - Year-over-year growth 2018-2022 (%)
    • EMEA - Market size and forecast 2017-2022
      • Table Burkitt lymphoma therapeutics market in EMEA - Market size and forecast 2017-2022 ($ mn)
      • Table Burkitt lymphoma therapeutics market in EMEA - Year-over-year growth 2018-2022 (%)
    • APAC - Market size and forecast 2017-2022
      • Table Burkitt lymphoma therapeutics market in APAC - Market size and forecast 2017-2022 ($ mn)
      • Table Burkitt lymphoma therapeutics market in APAC - Year-over-year growth 2018-2022 (%)
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
  • Market trends
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Biogen
      • Table Biogen: Overview
      • Table Biogen - Business segments
      • Table Biogen - Organizational developments
      • Table Biogen - Geographic focus
      • Table Biogen - Segment focus
      • Table Biogen - Key offerings
      • Table Biogen - Key customers
    • F. Hoffmann-La Roche
      • Table F. Hoffmann-La Roche: Overview
      • Table F. Hoffmann-La Roche - Business segments
      • Table F. Hoffmann-La Roche - Organizational developments
      • Table F. Hoffmann-La Roche - Geographic focus
      • Table F. Hoffmann-La Roche - Segment focus
      • Table F. Hoffmann-La Roche - Key offerings
      • Table F. Hoffmann-La Roche - Key customers
    • Merck Sharp & Dohme
      • Table Merck Sharp & Dohme: Overview
      • Table Merck Sharp & Dohme - Business segments
      • Table Merck Sharp & Dohme - Organizational developments
      • Table Merck Sharp & Dohme - Geographic focus
      • Table Merck Sharp & Dohme - Segment focus
      • Table Merck Sharp & Dohme - Key offerings
      • Table Merck Sharp & Dohme - Key customers
    • Novartis
      • Table Novartis: Overview
      • Table Novartis - Business segments
      • Table Novartis - Organizational developments
      • Table Novartis - Geographic focus
      • Table Novartis - Segment focus
      • Table Novartis - Key offerings
      • Table Novartis - Key customers
    • Spectrum Pharmaceuticals
      • Table Spectrum Pharmaceuticals: Overview
      • Table Spectrum Pharmaceuticals - Business segments
      • Table Spectrum Pharmaceuticals - Organizational developments
      • Table Spectrum Pharmaceuticals - Geographic focus
      • Table Spectrum Pharmaceuticals - Segment focus
      • Table Spectrum Pharmaceuticals - Key offerings
      • Table Spectrum Pharmaceuticals - Key customers
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report